ID   E95A-BL-28
AC   CVCL_C5V3
DR   Wikidata; Q116048913
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*01; B*08,16 (PubMed=3037521).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M567 ! BL-28
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
RX   PubMed=3037521; DOI=10.1073/pnas.84.13.4567; PMCID=PMC305131;
RA   Masucci M.G., Torsteinsdottir S., Colombani J., Brautbar C., Klein E.,
RA   Klein G.;
RT   "Down-regulation of class I HLA antigens and of the Epstein-Barr
RT   virus-encoded latent membrane protein in Burkitt lymphoma lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4567-4571(1987).
//